MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Annika Marx et al.|Cancer Cell|2017Cited by 607
Family matters: How MYC family oncogenes impact small cell lung cancerJohannes Brägelmann, Martin L. Sos, Stefanie Böhm et al.|Cell Cycle|2017Cited by 89
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Martin L. Sos, M Riedel et al.|Science Translational Medicine|2017Cited by 64